Evidence map›Paper›PMID 37947442›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2023

SIKs Regulate HDAC7 Stabilization and Cytokine Recall in Late-Stage T Cell Effector Differentiation.

Rachel S Helms, Alberto Marin-Gonzalez, Chirag H Patel, Im-Hong Sun, Jiayu Wen, Robert D Leone, Bridget Duvall, Run-Duo Gao, Taekjip Ha, Takashi Tsukamoto and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Post-translational modifications in CD8Frontiers in immunology · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Rachel S HelmsThe Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney-Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0001-7126-7122
Alberto Marin-GonzalezProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA.
Chirag H PatelThe Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney-Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
Im-Hong SunThe Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney-Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
Jiayu WenThe Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney-Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
Robert D LeoneThe Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney-Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
Bridget DuvallJohns Hopkins Drug Discovery, Baltimore, MD.
Run-Duo GaoJohns Hopkins Drug Discovery, Baltimore, MD.
Taekjip HaProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA.ORCID 0000-0003-2195-6258
Takashi TsukamotoJohns Hopkins Drug Discovery, Baltimore, MD.ORCID 0000-0002-0216-7520
Barbara S SlusherJohns Hopkins Drug Discovery, Baltimore, MD.
Joel L PomerantzDepartment of Biological Chemistry, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-5030-1018
Jonathan D PowellThe Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney-Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
Bloomberg (United States) · USJohns Hopkins University · USBoston Children's Hospital · US

Funding

Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
TR&D Project 3P41EB028239 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI Jordan Green, JONATHAN P SCHNECK · 2019 to 2026
$11.5M
Chromatin Function During Transcription and DNA Repair at Single Molecule Resolutionin Living CellsU01DK127432 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI HA, TAEKJIP, JOHNSON, MARGARET ELLEN · 2020 to 2024
$3.5M
Mechanisms of Control of Lymphocyte Activation and Proliferation by a Critical Signaling IntegratorR01AI148143 · NIAID · JOHNS HOPKINS UNIVERSITY · PI POMERANTZ, JOEL L · 2020 to 2024
$2.3M
ECOLOGY OF EMERGING ARENAVIRUSES IN SOUTHWESTERN U.S.R01AI041435 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI FULHORST, CHARLES F · 1997 to 2004
$1.6M
Translational Design of Medical DevicesR25EB018239 · NIBIB · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KOTCHE, MIIRI · 2014 to 2018
$216k
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR001079NIAID NIH HHS R01 AI041435NIAID NIH HHS R01 AI148143NIBIB NIH HHS P41 EB028239NIBIB NIH HHS R25 EB018239NIDDK NIH HHS U01 DK127432
6 · The paper itself

Abstract

Understanding the mechanisms underlying the acquisition and maintenance of effector function during T cell differentiation is important to unraveling how these processes can be dysregulated in the context of disease and manipulated for therapeutic intervention. In this study, we report the identification of a previously unappreciated regulator of murine T cell differentiation through the evaluation of a previously unreported activity of the kinase inhibitor, BioE-1197. Specifically, we demonstrate that liver kinase B1 (LKB1)-mediated activation of salt-inducible kinases epigenetically regulates cytokine recall potential in effector CD8+ and Th1 cells. Evaluation of this phenotype revealed that salt-inducible kinase-mediated phosphorylation-dependent stabilization of histone deacetylase 7 (HDAC7) occurred during late-stage effector differentiation. HDAC7 stabilization increased nuclear HDAC7 levels, which correlated with total and cytokine loci-specific reductions in the activating transcription mark histone 3 lysine 27 acetylation (H3K27Ac). Accordingly, HDAC7 stabilization diminished transcriptional induction of cytokine genes upon restimulation. Inhibition of this pathway during differentiation produced effector T cells epigenetically poised for enhanced cytokine recall. This work identifies a previously unrecognized target for enhancing effector T cell functionality.

Indexed as

CytokinesProtein Processing, Post-TranslationalProtein Serine-Threonine KinasesAnimalsCell DifferentiationHistone DeacetylasesMicePhosphorylationCytokinesHdac7 protein, mouseHistone DeacetylasesProtein Serine-Threonine Kinases

Identifiers

PMID37947442
PMCPMC10842463
OpenAlexW4388573020

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.